Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma
Authors
Abstract
Bortezomib is superior to high-dose dexamethasone for the treatment of patients with multiple myeloma who have had a relapse after one to three previous therapies.
Discussion
No takes yet. Share an insight, caveat, or question.
Cite This Study
Richardson et al. (2005) studied this question.